|
Index of reports
> All cases (62)
> Cases with Blood Pressure Decreased (7)
Below is the selection of adverse event reports related to Indocin (Indomethacin) that includes all cases where reactions include blood pressure decreased.
Adverse event in 60 year old male receiving Indocin (Indomethacin)
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: 60 year old male, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Anticonvulsant Drug Level Decreased, Blood Pressure Decreased, Lethargy, Convulsion
Suspect drug(s):
Benadryl
Indication: Rash
Start date: 2007-09-20
Warfarin Sodium
Dosage: 2mg qd, oral
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2007-09-09
Indocin
Dosage: 1 capsule tid, oral
Administration route: Oral
Start date: 2007-09-20
End date: 2007-09-23
Other drugs received by patient: Acetaminophen; Dilantin Kapseal; Primidone; Multi-Vitamins
Adverse event in 60 year old male receiving Indocin (Indomethacin)
Reported by a consumer/non-health professional from United States on 2007-10-17
Patient: 60 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Pruritus, Drug Interaction, Blood Pressure Decreased, Convulsion, Lethargy, Rash Macular
Suspect drug(s):
Indocin
Administration route: Oral
Start date: 2007-09-20
End date: 2007-09-23
Warfarin Sodium
Administration route: Oral
Indication: Thrombosis Prophylaxis
Start date: 2007-09-09
Dilantin
Administration route: Oral
Indication: Convulsion
Dilantin
Administration route: Oral
Indication: Prophylaxis
Other drugs received by patient: Primidone; Tylenol (Caplet); Vitamins (Unspecified)
Adverse event in male receiving Indocin (Indomethacin)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-05-01
Patient: male
Adverse reactions / side effects: Hyperkalaemia, Disseminated Intravascular Coagulation, Neonatal Disorder, Cerebral Haemorrhage Neonatal, Neonatal Infection, Electrocardiogram QRS Complex Prolonged, Patent Ductus Arteriosus, Arrhythmia Neonatal, Neonatal Cardiac Failure, Bradycardia Neonatal, Staphylococcal Infection, NO Therapeutic Response, Platelet Count Decreased, Necrotising Fasciitis, Blood Pressure Decreased, Neutrophil Count Decreased, Shock
Adverse event resulted in: death
Suspect drug(s):
Indocin
Dosage: 0.06 mg; tid; iv
Indication: Patent Ductus Arteriosus
Start date: 2006-06-10
End date: 2006-06-11
Solu-Cortef
Dosage: 2 mg; qd; iv
Indication: Shock
Start date: 2006-06-02
End date: 2006-06-02
Solu-Cortef
Dosage: 2 mg; qd; iv
Indication: Shock
Start date: 2006-06-13
End date: 2006-06-13
Pitressin
Dosage: 1.92 u; qd; iv
Indication: Shock
Start date: 2006-06-08
End date: 2006-06-14
Other drugs received by patient: Ampiclox
Adverse event in receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-04-09
Patient: , weighing 1.0 kg (2.2 pounds)
Adverse reactions / side effects: Hyperkalaemia, Disseminated Intravascular Coagulation, Haemorrhage Intracranial, Methicillin-Resistant Staphylococcal Aureus Test Positive, Electrocardiogram QRS Complex Prolonged, Sepsis, Bradycardia, Blood Pressure Decreased, Necrotising Fasciitis
Adverse event resulted in: death
Suspect drug(s):
Hydrocortone Injection
Indication: Blood Pressure Decreased
Hydrocortone Injection
Indication: Urine Output Decreased
Indocin
Amikacina
Indication: Sepsis
Adverse event in 56 year old male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-03-15
Patient: 56 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Tachycardia, Compartment Syndrome, Depressed Level of Consciousness, Acquired Haemophilia, Blood Pressure Decreased, Haematoma
Adverse event resulted in: death
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Pustular Psoriasis
Tigason
Administration route: Oral
Indication: Pustular Psoriasis
Roxithromycin
Administration route: Oral
Indication: Pustular Psoriasis
Tacalcitol
Administration route: Topical
Indication: Pustular Psoriasis
Difluprednate
Administration route: Topical
Indication: Pustular Psoriasis
Betamethasone Butyrate Propionate
Administration route: Topical
Indication: Pustular Psoriasis
[therapy Unspecified]
Administration route: Topical
Indication: Pustular Psoriasis
Furosemide
Administration route: Oral
Indication: Oedema Peripheral
Adverse event in 56 year old male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-03-02
Patient: 56 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Renal Tubular Disorder, Tachycardia, Compartment Syndrome, Acquired Haemophilia, Haemorrhoidal Haemorrhage, Activated Partial Thromboplastin Time Prolonged, Cardio-Respiratory Arrest, Depressed Level of Consciousness, Myoglobin Blood Increased, Coagulation Time Prolonged, Blood Pressure Decreased, Haematoma
Adverse event resulted in: death
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Pustular Psoriasis
Tigason
Administration route: Oral
Indication: Pustular Psoriasis
Roxithromycin
Administration route: Oral
Indication: Pustular Psoriasis
Tacalcitol
Administration route: Topical
Indication: Pustular Psoriasis
Difluprednate
Administration route: Topical
Indication: Pustular Psoriasis
Betamethasone
Administration route: Topical
Indication: Pustular Psoriasis
[therapy Unspecified]
Administration route: Topical
Indication: Pustular Psoriasis
Furosemide
Administration route: Oral
Indication: Oedema Peripheral
Adverse event in 56 year old male receiving Indocin (Indomethacin)
Reported by a physician from Japan on 2007-02-22
Patient: 56 year old male, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Tachycardia, Compartment Syndrome, Depressed Level of Consciousness, Acquired Haemophilia, Blood Pressure Decreased, Haematoma
Adverse event resulted in: death
Suspect drug(s):
Indocin
Administration route: Oral
Indication: Pustular Psoriasis
Tigason
Administration route: Oral
Indication: Pustular Psoriasis
Roxithromycin
Administration route: Oral
Indication: Pustular Psoriasis
Tacalcitol
Administration route: Topical
Indication: Pustular Psoriasis
Difluprednate
Administration route: Topical
Indication: Pustular Psoriasis
Betamethasone Butyrate Propionate
Administration route: Topical
Indication: Pustular Psoriasis
[therapy Unspecified]
Administration route: Topical
Indication: Pustular Psoriasis
Furosemide
Administration route: Oral
Indication: Oedema Peripheral
|
